المؤلفون: Ruaraidh Hill, Christian Hierländer, Carolina Zampirolli Dias, Tomasz Bochenek, Ott Laius, Lars L. Gustafsson, Tracey-Lea Laba, Arianit Jakupi, Øyvind Melien, Wija Oortwijn, Luka Voncina, Durhane Wong-Rieger, Caridad Pontes, Jf Hans Piepenbrink, Magdalene Wladysiuk, Guenka Petrova, Patricia Vella Bonanno, Corinne Zara, Robert Sauermann, Steven Simoens, Olayinka O Ogunleye, Amanj Kurdi, Wouter Hamelinck, Wania Cristina Silva, Dzintars Gotham, Seung Jin Bae, Johanna C Meyer, Roberta Joppi, Janet Wale, Admir Malaj, John Yfantopoulos, Gisbert Selke, Angela Timoney, Brian Godman, Vincent de Valk, Andrew Hill, Merce Obach Cortadellas, D Tomek, Hye-Young Kwon, Irene Langner, Jurij Fürst, Iva Selke Krulichová, Antony P. Martin, Jolanta Gulbinovič, Iris Hoxha, Eleonora Allocati, Stuart McTaggart, Ieva Greiciute-Kuprijanov, Vanda Marković-Peković, Ileana Mardare

المساهمون: Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Laba, Tracey-Lea, Hill, Ruaraidh

المصدر: Expert review of pharmacoeconomics and outcomes research, Abingdon : Taylor and Francis Ltd., 2021, vol. 21, iss. 4, p. 527-540
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 527-540
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Expert Review of Pharmacoeconomics and Outcomes Research, 21, 4, pp. 527-540
Expert review of pharmacoeconomics & outcomes research

مصطلحات موضوعية: Transparency (market), Amortization (business), Medical care -- Cost control, Alternative pricing approaches, cancer medicines, europe, managed entry agreements, minimum effectiveness criteria, multicriteria decision analyses, payers, tiered pricing approaches, transparent pricing approaches, 0302 clinical medicine, Neoplasms, Health care, Pharmacology (medical), Confidentiality, 030212 general & internal medicine, Pharmacology & Pharmacy, Reimbursement, health care economics and organizations, Public economics, 030503 health policy & services, Health Policy, General Medicine, Europe, Models, Economic, Value (economics), Health Policy & Services, Costs and Cost Analysis, 0305 other medical science, Life Sciences & Biomedicine, Scrutiny, Cancer -- Treatment -- Europe, Antineoplastic Agents, Medical care -- Cost control -- Europe, Drug Costs, Patents as Topic, Reimbursement Mechanisms, 03 medical and health sciences, Drug Development, Humans, Drugs -- Law and legislation -- Decision making, 1115 Pharmacology and Pharmaceutical Sciences, 1117 Public Health and Health Services, 1402 Applied Economics, Science & Technology, business.industry, lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4], Health Care Sciences & Services, Sustainability, Business, RA, Delivery of Health Care

وصف الملف: application/pdf; Print-Electronic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dfe77330e4296c7333cde6b78e19b86
https://repository.vu.lt/VU:ELABAPDB88291411&prefLang=en_US

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.